2 mg semaglutide to tirzepatide Semaglutide: A Clinician's 2026 Guide Dosing, Weight Loss & Safety Tirzepatide found to be more

Fatigue and dizziness : Some patients report mild fatigue, dizziness, or lightheadedness alongside thirst, particularly early in treatment

Fatigue can appear within 12 to 36 hours of injection

We identified patents and their patent family members that could either be used to deter other branded competitors from upstream research and development of competing similar products (e.g., me-too versions), or which could be used downstream to block/delay generic entrants

These may include nausea, decreased appetite, vomiting, constipation, diarrhea, bloating, or abdominal discomfort

The metabolic impact of tirzepatide throughout its weekly cycle is far more gradual and sustained than the sharp peaks and troughs that would be needed to meaningfully shift daily energy expenditure